Synthesis of 2-[2-(2,6-dichlorophenyl)amino]phenylmethyl-3-[4-(2-substitutedphenyl4-oxo-thiazolidinyl)aryl]-6-bromo quinazolin-4(3H)ones VI a-j have been achieved from the starting material 2-[(2,6-dichlorophenyl)amino] phenylacetic acid I to benzoxazine III, Further reaction with p-phenylindiamine and substituted aromatic aldehyde gave 2-[2-(2,6dichlorophenyl)amino]phenyl methyl-3-(4-aminoaryl)-6-bromo quinazolin-4(3H)-ones IV and 2-[2-(2,6-dichlorophenyl)amino]phenylmethyl-3-[4-(2-substituted arylidene)aryl]-6-bromo quinazolin-4(3H)ones V a-j respectively. V a-j on cyclization with thioglycolic acid gave VI a-j . All the synthesized compounds have been characterized on the basis of elemental analysis, IR and 1 H-NMR spectral data. They were screened for antibacterial and antifungal activity at two concentrations and compared with the standard drugs penicillin-G, ampicillin, and amoxicillin. The compounds containing 4-OCH 3 and 3, 4, 5-(OCH 3 ) 3 showed good activity, compared with the standard drugs.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2007) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: